TGFB1 and cancer: Furthermore, IMC analysis of pre-treatment biopsies revealed high TGFβ counts in a subgroup of non-responders (P = 0.37; Fig. 5h), with high levels of TGFβ in both cancer cells and CAFs, as well as extracellular matrix deposits (Extended Data Fig. 6c,d).